S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ENTA Enanta Pharmaceuticals Inc

13.875

0.135 (0.98%)

Last Updated: 10:04:11

Delayed by 15 minutes

Enanta Pharma EPS misses by $0.12, misses on revenue

To read the full story on Seeking Alpha, click here.

Enanta Pharmaceuticals (NASDAQ:ENTA)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Enanta Pharmaceuticals Charts.

Enanta Pharmaceuticals (NASDAQ:ENTA)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Enanta Pharmaceuticals Charts.

Enanta Pharmaceuticals Inc News

Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tuesday 30 April 2024 (1 day ago) • Business Wire

Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
Tuesday 30 April 2024 (1 day ago) • Business Wire

Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
Monday 29 April 2024 (2 days ago) • Business Wire

Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
Wednesday 17 April 2024 (2 weeks ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
Wednesday 6 March 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

More Enanta Pharmaceuticals Inc News Articles

Global Developments (PK)

Yuenglings Ice Cream (PK)

FBEC Worldwide (PK)

CBD of Denver (PK)

Virexit Technologies (PK)

Elite Pharmaceuticals (QB)

Tonner One World (PK)

Branded Legacy (PK)

Impact Fusion (PK)

BlueFire Equipment (PK)

Canopus Biopharma (PK)

International Star (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions